Brief: 3D Medicines Sees Revenue For Six Months Between RMB343.8 Million To RMB361.4 Million

3D Medicines

07/07/2023 12:03

July 7 (Reuters) - 3D Medicines Inc  1244.HK :
    * SEES REVENUE FOR SIX MONTHS BETWEEN RMB343.8 MILLION TO
RMB361.4
MILLION
    * GROSS PROFIT FOR SIX MONTHS TO BE WITHIN RANGE OF RMB319.4
MILLION TO RMB335.8 MILLION
    * EXPECTED RESULTS DUE TO INCREASED REVENUE AND GROSS PROFIT
OF
PRODUCT, NAMELY ENVAFOLIMAB (®)


Further company coverage:  1244.HK 

 ((reuters.briefs@thomsonreuters.com;))